In the current month’s ABA Law Practice Journal, Susan Saltonstall Duncan of Rainmaking Oasis wrote a nice, concise commentary about Pfizer’s relatively new model for engaging outside counsel.  While other corporate legal departments have branded their particular models for internal operations (DuPont) and engaging and paying for law firm representation (FMC Technologies’ ACES program), Pfizer seems uniquely committed […]

Read More →